STOCKS TELEGRAPH

Tag: SDGR

  • Schrödinger (SDGR) Stock Rises Following Solid Q3 2024 Performance

    Schrödinger (SDGR) Stock Rises Following Solid Q3 2024 Performance

    Following the release of its Q3 2024 earnings report, Schrödinger, Inc. (NASDAQ: SDGR) shares are on a notable increase this session. Investor confidence was demonstrated by the surge in SDGR stock price, which increased 10.03% to trade at $21.50 as of the last check.

    Notable Financials

    Schrödinger (SDGR) reported $35.3 million in total revenue, which was fueled by both other revenue and core business activities. Notably, other revenue—which includes interest income and adjustments to the fair value of equity investments—rose sharply to $30.2 million from $8.7 million in the previous year.

    Positive changes in its equity investment valuation are reflected in this improvement. Compared to the $62.0 million loss recorded during the same time previous year, net loss for the reported period was $38.1 million.

    Strategic Alliance with Novartis

    An important strategic move was the announcement of Schrödinger and Novartis of a multi-target research and licensing partnership. Novartis will pay Schrödinger $150 million up front as part of the deal, with milestone payments of up to $892 million possible based on advancements in research, development, and regulations.

    Additionally, royalties on net sales of Novartis-developed medicines and commercial milestones could total up to $1.38 billion for SDGR. The partnership also includes an expanded software licensing agreement, providing Novartis with enhanced access to the company’s advanced computational modeling and informatics platform.

    Exciting Developments in Drug Discovery

    SDGR continues to make strides in the pharmaceutical sector through its co-founded companies. In November, Nimbus Therapeutics announced updated data for NDI-101150, a promising HPK1 inhibitor for solid tumors. Furthermore, in October, Ajax Therapeutics initiated its Phase 1 study of AJ1-11095, a novel JAK2 inhibitor for myelofibrosis. These developments underscore SDGR’s ongoing commitment to innovative therapeutic solutions.

    Key Acquisition and Future Prospects

    In another significant event, Eli Lilly completed its $3.2 billion acquisition of Morphic, a company co-founded by Schrödinger. SDGR continues to hold a stake in Morphic and is entitled to royalties from its clinical development programs, further enhancing its financial outlook.

  • 13 Trending Stocks in Health Information Services Industry

    13 Trending Stocks in Health Information Services Industry

    As investors weighed the stimulus vote of Monday against the emergence of a new ‎coronavirus strain ‎in the UK, US equities ended mixed on Tuesday.
‎

    The Senate approved the measure Monday night after months of negotiations over ‎additional fiscal ‎support. The bill funds the government through September 30 and includes ‎a new stimulus of $900 ‎billion. Also, the package includes $300 in additional federal ‎unemployment benefits and $600 in direct ‎payments. 
‎

    Some of the key players in the Health Information Services sector were:

‎‎

    NantHealth Inc. (NASDAQ:NH) shares were trading up 21.50% at $3.56 at the ‎time of writing on Tuesday.‎

    NantHealth Inc. (NASDAQ:NH) share price went from a low point around $0.92 ‎to briefly over $6.60 in past 52 weeks, though shares have since pulled back to $3.56. NH market cap ‎has remained high, hitting $427.88M at the time of writing, giving it price-to-sales ratio of more than ‎‎5.

    ‎If we look at the recent analyst rating NH, Canaccord Genuity reiterated ‎coverage on NH shares with a Buy rating and a $3.75 price target, which implies ‎room for 0.19% upside momentum this year.

    HMS Holdings Corp. (HMSY) last closed at $36.58, in a 52-week range of $18.19 ‎to $36.75. The company recently reported an agreement with Veritas Capital-backed Gainwell ‎Technologies, whereby Gainwell will acquire HMS. Analysts have a consensus price target of ‎‎$35.09.

    Teladoc Health Inc. (TDOC) stock soar by 3.15% to $206.04. The most recent ‎rating by Evercore ISI, on December 22, 2020, is at an In-line.

    American Well Corporation (NYSE:AMWL) Shares headed rising, higher as much ‎as 5.90%. The most recent rating by Stifel, on December 18, 2020, is at a Hold.

    Veeva Systems Inc. (NYSE:VEEV) rose 5.76% after gaining more than $15.61 on ‎Tuesday. Veeva reported on December 15, 2020, that Integra LifeSciences has selected Veeva Vault ‎CDMS for clinical data management. ‎

    Change Healthcare Inc. (CHNG) last closed at $18.83, in a 52-week range of ‎‎$6.18 to $18.70 following the announcement of successful introduction of its first cloud-based medical ‎tools for radiologists and other specialties along with its roadmap to help healthcare organizations ‎begin their migration of medical imaging to the cloud. Analysts have a consensus price target of ‎‎$20.39.

    GoodRx Holdings Inc. (GDRX) stock soar by 3.49% to $48.32 after announcing ‎recognition from workplace culture site Comparably for its company culture and leadership. The most ‎recent rating by RBC Capital Mkts, on November 19, 2020, is at an Outperform.

    Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) Shares headed rising, ‎higher as much as 2.15%. The company announced on December 17, 2020, that it is dedicating ‎extensive resources to ensure its clients are prepared to maximize functionality within its solutions to ‎respond to the COVID-19 pandemic. The most recent rating by Argus, on November 11, 2020, is at a ‎Buy.

    HealthEquity Inc. (NASDAQ:HQY) rose 2.27% after gaining more than $1.51 on ‎Tuesday. The company reported on December 8, 2020, that revenue for the third quarter ended ‎October 31, 2020 of $179.4 million grew 14% compared to $157.1 million for the third quarter ended ‎October 31, 2019.

    ‎Cerner Corporation (CERN) last closed at $77.38, in a 52-week range of $53.08 to ‎‎$80.90. The firm on December 16, 2020 revealed an agreement to acquire health division of Kantar. ‎Analysts have a consensus price target of $78.23.

    ‎1Life Healthcare Inc. (ONEM) stock soar by 3.97% to $43.26. The most recent ‎rating by Credit Suisse, on October 30, 2020, is at an Outperform.

    ‎So-Young International Inc. (NASDAQ:SY) Shares headed falling, lower as much ‎as -7.41%. The most recent rating by Deutsche Bank, on April 23, 2020, is at a Buy.

    ‎Schrodinger Inc. (NASDAQ:SDGR) rose 0.85% after gaining more than $0.7 on ‎Tuesday.